RxDoctor Payments Data

Benjamin Ricciardi, MD

Adult Reconstructive Orthopaedic Surgery · Rochester, NYNPI 1255574844

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $7,313 of the $11,448 with a category attached, or 63.9%. Depuy Synthes Products, Inc. accounts for 65.5% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2021 at $8,643 and has fallen 91.2% since, to $762 in 2025. That places this record below the midpoint for adult reconstructive orthopaedic surgery clinicians in NY, where the typical reported total is $11,547.

$11,448in general payments, 2019–2025

Across 47 payments — averaging $243.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Depuy Synthes Products, Inc.$7K
  • Stryker$2K
  • Johnson & Johnson$1K
  • Zimmer Biomet$172
  • Davol Inc.$137
  • Medical Device Business Services, Inc.$127
  • plus $109 from 1 others

What the payments were for

  • Consulting fees$7,31364%
  • Travel & lodging$1,09210%
  • Food & beverage$3,04327%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,448 in reported general payments places this provider in the 45th percentile of 85 adult reconstructive orthopaedic surgery providers in New York.

See all adult reconstructive orthopaedic surgery providers in New York

Medicare billing

Part B allowed, 2024
$72,043
Medicare patients
152
Services billed
2,072

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Amoxicillin21$35
Meloxicam14$31

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Rochester

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →